Patents by Inventor David M. Canter

David M. Canter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7582421
    Abstract: This application includes methods for detecting single nucleotide polymorphisms (SNPs) in a sample using an electronically addressable microchip having a plurality of test sites. A sample nucleic acid is electronically biased, concentrated at, and immobilized to a test site on the microchip. A mixture comprising a first labeled probe and a second labeled probe is electronically hybridized to the sample nucleic acid to form first or second hybridized complexes. The first labeled probe is perfectly complementary to the first sample nucleic acid and the second labeled probe is complementary to the sample nucleic acid and contains a nucleotide that forms a mismatch with the nucleotide at the site of the polymorphism. The first or second hybridized complexes are detected by determining a signal intensity of the label of the first or second probe.
    Type: Grant
    Filed: September 16, 2002
    Date of Patent: September 1, 2009
    Assignee: Nanogen, Inc.
    Inventors: Ronald G. Sosnowski, Michael I. Nerenberg, David M. Canter, Ray R. Radtkey, Ling Wang, James P. O'Connell
  • Publication number: 20030073122
    Abstract: Methods are provided for the analysis and determination of the nature of single nucleic acid polymorphisms (SNPs) in a genetic target. In one method of this invention, the nature of the SNPs in the genetic target is determined by the steps of providing a plurality of hybridization complexes arrayed on a plurality of test sites on an electronically bioactive microchip, where the hybridization complex includes at least a nucleic acid target containing a SNP, a stabilizer probe having a sequence complementary to the target sequence and/or reporter probe, and a reporter probe having a selected sequence complementary to either the stabilizer or the same target sequence strand wherein a selected sequence of the reporter includes either a wild type nucleotide or a nucleotide corresponding to the SNP of the target.
    Type: Application
    Filed: September 16, 2002
    Publication date: April 17, 2003
    Applicant: Nanogen, Inc.
    Inventors: Ronald G. Sosnowski, Michael I. Nerenberg, David M. Canter, Ray R. Radtkey, Ling Wang, James P. O'Connell
  • Patent number: 6468742
    Abstract: Methods are provided for the analysis and determination of the nature of single nucleic acid polymorphisms (SNPs) in a genetic target. In one method of this invention, the nature of the SNPs in the genetic target is determined by the steps of providing a plurality of hybridization complexes arrayed on a plurality of test sites on an electronically bioactive microchip, where the hybridization complex includes at least a nucleic acid target containing a SNP, a stabilizer probe having a sequence complementary to the target sequence and/or reporter probe, and a reporter probe having a selected sequence complementary to either the stabilizer or the same target sequence strand wherein a selected sequence of the reporter includes either a wild type nucleotide or a nucleotide corresponding to the SNP of the target.
    Type: Grant
    Filed: April 12, 1999
    Date of Patent: October 22, 2002
    Assignee: Nanogen, Inc.
    Inventors: Michael I. Nerenberg, David M. Canter, Ray R. Radtkey, Ling Wang, James P. O'connell, Ronald G. Sosnowski
  • Publication number: 20010014449
    Abstract: Methods are provided for the analysis and determination of the nature of single nucleic acid polymorphisms (SNPs) in a genetic target. In one method of this invention, the nature of the SNPs in the genetic target is determined by the steps of providing a plurality of hybridization complexes arrayed on a plurality of test sites on an electronically bioactive microchip, where the hybridization complex includes at least a nucleic acid target containing a SNP, a stabilizer probe having a sequence complementary to the target sequence and/or reporter probe, and a reporter probe having a selected sequence complementary to either the stabilizer or the same target sequence strand wherein a selected sequence of the reporter includes either a wild type nucleotide or a nucleotide corresponding to the SNP of the target.
    Type: Application
    Filed: April 12, 1999
    Publication date: August 16, 2001
    Inventors: MICHAEL I. NERENBERG, DAVID M. CANTER, RAY R. RADTKEY, LING WANG, JAMES P. O'CONNELL